Employees: 11-50
Total raised: $9.2M
Founded date: 2006
Investors 2
| Date | Name | Website |
| - | Strategic ... | en.sip-vc.... |
| - | Oita Ventu... | oita-vc.co... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 14.02.2014 | Series D | $9.2M | - |
Mentions in press and media 5
| Date | Title | Description |
| 01.04.2023 | REGiMMUNE Limited Licenses the Rights to Develop and Commercialize RGI-2001 To San Fu Biotech in Major Asian Countries | TAIPEI, Taiwan–(BUSINESS WIRE)–April 1, 2023– REGiMMUNE Limited (REGiMMUNE), a biotech company focused on creating innovative immunotherapies for immune disorders and cancer, and San Fu Biotech (SFB), a subsidiary of San Fu Chemical Co., Lt... |
| 19.12.2022 | REGiMMUNE Presented Positive Results of RGI-2001 in the Reduction of Acute GvHD from Phase 2b Study at the 2022 ASH Annual Meeting | RGI-2001 was well tolerated and associated with a meaningful reduction in the incidence of severe acute GvHD TAIPEI, Taiwan–(BUSINESS WIRE)–December 20, 2022– REGiMMUNE Limited, a clinical-stage biopharmaceutical company developing innovati... |
| 07.11.2022 | REGiMMUNE to Present Results from the Phase 2b Study of RGI-2001 at the 2022 American Society of Hematology Annual Meeting | TAIPEI, Taiwan–(BUSINESS WIRE)–November 7, 2022– REGiMMUNE Limited, a clinical-stage biopharmaceutical company focused on creating innovative immunotherapies for immune disorders and cancer, today announced that the Phase 2b clinical data f... |
| 14.02.2014 | Regimmune Closes $9.2M Series D Financing | Regimmune Corporation, a Tokyo, Japan-based biotechnology company, closed a $9.2m Series D financing. The round was led by Japan Asia Investment Corporation (JAIC) and Nippon Venture Capital Corp (NVCC), with participation from new investor... |
| 14.02.2014 | REGiMMUNE Completes $9.2M Series D | TOKYO, JAPAN, REGiMMUNE Corporation announced the closing of a Series D financing earlier this month. >> Click here for more funding data on REGiMMUNE >> To export REGiMMUNE funding data to PDF and Excel, click here REGiM... |